| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |